Jõgeva Valla Perearstikeskus OÜ

In liquidation Registry code 16543412 OÜ Palamuse alevik Registered 28 Jul 2022
Compare

Jõgeva Valla Perearstikeskus OÜ is a OÜ based in Palamuse alevik, registry code 16543412, status: in liquidation. Main activity: General medical practice activities. Its annual report for 2025 shows revenue of €12 653 and 0 employees.

Turnover
—
State taxes
330 €
↑ 33.1% vs Q2 2026
Labour taxes
330 €
↑ 33.1% vs Q2 2026
Employees
—

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Human health activities · EMTAK 86

  • Revenue · 2025 12 653 €
    industry median 20 811 € · companies in the industry: 3 373
  • Net profit margin · 2025 -132.5 %
    industry median 8.3 % · companies in the industry: 2 759

Taxes and turnover

Q3 2023 – Q3 2026
Labour taxes per employee, € Q2 2025: 1 119 € · industry median 2 253 € · above 26% of the industry
01 0002 0003 0004 0005 000Q3 2023 Company: 3 413 € Industry median: 2 109 €Q3·23Q4 2023 Company: 2 502 € Industry median: 2 068 €Q1 2024 Company: 3 522 € Industry median: 2 162 €Q1·24Q2 2024 Company: 2 516 € Industry median: 2 205 €Q3 2024 Company: 2 749 € Industry median: 2 205 €Q3·24Q4 2024 Company: 4 376 € Industry median: 2 146 €Q1 2025 Company: — Industry median: 2 257 €Q1·25Q2 2025 Company: 1 119 € Industry median: 2 253 €Q3 2025 Company: — Industry median: 2 267 €Q3·25Q1 2026 Company: — Industry median: 2 195 €Q2 2026 Company: — Industry median: 2 159 €Q2·26Q3 2026 Company: — Industry median: 2 177 €Q3·2601 0002 0003 0004 0005 000Q3 2024 Company: 2 749 € Industry median: 2 205 €Q4 2024 Company: 4 376 € Industry median: 2 146 €Q4·24Q1 2025 Company: — Industry median: 2 257 €Q2 2025 Company: 1 119 € Industry median: 2 253 €Q2·25Q3 2025 Company: — Industry median: 2 267 €Q1 2026 Company: — Industry median: 2 195 €Q1·26Q2 2026 Company: — Industry median: 2 159 €Q3 2026 Company: — Industry median: 2 177 €Q3·26
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q2 2025: 1
0246810Q3 2023 Company: 5Q3·23Q4 2023 Company: 6Q1 2024 Company: 6Q1·24Q2 2024 Company: 7Q3 2024 Company: 9Q3·24Q4 2024 Company: 9Q1 2025 Company: —Q1·25Q2 2025 Company: 1Q3 2025 Company: —Q3·25Q1 2026 Company: —Q2 2026 Company: —Q2·26Q3 2026 Company: —Q3·260246810Q3 2024 Company: 9Q4 2024 Company: 9Q4·24Q1 2025 Company: —Q2 2025 Company: 1Q2·25Q3 2025 Company: —Q1 2026 Company: —Q1·26Q2 2026 Company: —Q3 2026 Company: —Q3·26
State taxes, € Q3 2026: 330 € · +33.1% vs Q2 2026
010 00020 00030 00040 000Q3 2023 Company: 15 946 €Q3·23Q4 2023 Company: 14 073 €Q1 2024 Company: 19 933 €Q1·24Q2 2024 Company: 16 832 €Q3 2024 Company: 23 586 €Q3·24Q4 2024 Company: 37 304 €Q1 2025 Company: 37 195 €Q1·25Q2 2025 Company: 1 119 €Q3 2025 Company: 1 171 €Q3·25Q1 2026 Company: 215 €Q2 2026 Company: 248 €Q2·26Q3 2026 Company: 330 €Q3·26010 00020 00030 00040 000Q3 2024 Company: 23 586 €Q4 2024 Company: 37 304 €Q4·24Q1 2025 Company: 37 195 €Q2 2025 Company: 1 119 €Q2·25Q3 2025 Company: 1 171 €Q1 2026 Company: 215 €Q1·26Q2 2026 Company: 248 €Q3 2026 Company: 330 €Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 — 330 330 —
Q2 2026 — 248 248 —
Q1 2026 — 215 215 —
Q3 2025 — 1 171 1 193 —
Q2 2025 — 1 119 1 119 1
Q1 2025 — 37 195 39 456 —
Q4 2024 — 37 304 39 382 9
Q3 2024 — 23 586 24 740 9
Q2 2024 — 16 832 17 612 7
Q1 2024 — 19 933 21 133 6
Q4 2023 — 14 073 15 010 6
Q3 2023 — 15 946 17 065 5
Q2 2023 — 16 045 17 144 5
Q1 2023 — 14 624 15 646 5
Q4 2022 — 9 705 10 381 5
Q3 2022 — — — 4

Financials by year

2022 – 2026
Revenue, € thousand 2025: 12 653 € · −97.9% vs 2024 · industry median 20 811 € · above 43% of the industry
02004006002022 Company: 83 568 € Industry median: 20 030 €20222023 Company: 299 407 € Industry median: 19 469 €20232024 Company: 590 929 € Industry median: 20 000 €20242025 Company: 12 653 € Industry median: 20 811 €20252026 Company: — Industry median: 7 790 €202602004006002022 Company: 83 568 € Industry median: 20 030 €20222023 Company: 299 407 € Industry median: 19 469 €2024 Company: 590 929 € Industry median: 20 000 €20242025 Company: 12 653 € Industry median: 20 811 €2026 Company: — Industry median: 7 790 €2026
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: -16 771 € · −125.2% vs 2024 · industry median 1 071 € · above 2% of the industry
-20 000020 00040 00060 00080 0002022 Company: -897 € Industry median: 1 525 €20222023 Company: 19 963 € Industry median: 1 745 €20232024 Company: 66 475 € Industry median: 1 621 €20242025 Company: -16 771 € Industry median: 1 071 €20252026 Company: — Industry median: 948 €2026-20 000020 00040 00060 00080 0002022 Company: -897 € Industry median: 1 525 €20222023 Company: 19 963 € Industry median: 1 745 €2024 Company: 66 475 € Industry median: 1 621 €20242025 Company: -16 771 € Industry median: 1 071 €2026 Company: — Industry median: 948 €2026
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: -132.5 % · −143.8 pp vs the year before · industry median 8.3 % · above 2% of the industry
-150-100-500502022 Company: -1.1 % Industry median: 11.3 %20222023 Company: 6.7 % Industry median: 11.4 %20232024 Company: 11.2 % Industry median: 10.7 %20242025 Company: -132.5 % Industry median: 8.3 %20252026 Company: — Industry median: 30.0 %2026-150-100-500502022 Company: -1.1 % Industry median: 11.3 %20222023 Company: 6.7 % Industry median: 11.4 %2024 Company: 11.2 % Industry median: 10.7 %20242025 Company: -132.5 % Industry median: 8.3 %2026 Company: — Industry median: 30.0 %2026
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € thousand 2025: 89 019 € · −47.8% vs 2024
0501001502002022 Company: 39 870 €20222023 Company: 69 769 €20232024 Company: 170 676 €20242025 Company: 89 019 €20252026 Company: —20260501001502002022 Company: 39 870 €20222023 Company: 69 769 €2024 Company: 170 676 €20242025 Company: 89 019 €2026 Company: —2026
Equity, € thousand 2025: 88 770 € · −15.9% vs 2024
02550751001252022 Company: 19 103 €20222023 Company: 39 066 €20232024 Company: 105 541 €20242025 Company: 88 770 €20252026 Company: —202602550751001252022 Company: 19 103 €20222023 Company: 39 066 €2024 Company: 105 541 €20242025 Company: 88 770 €2026 Company: —2026
Employees 2026: 0 · industry median 2 · above 2% of the industry
024682022 Company: 1 Industry median: 220222023 Company: 4 Industry median: 220232024 Company: 8 Industry median: 220242025 Company: 0 Industry median: 220252026 Company: 0 Industry median: 22026024682022 Company: 1 Industry median: 220222023 Company: 4 Industry median: 22024 Company: 8 Industry median: 220242025 Company: 0 Industry median: 22026 Company: 0 Industry median: 22026
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2026 — — — — — 0
2025 12 653 -16 771 7 481 89 019 88 770 0
2024 590 929 66 475 306 202 170 676 105 541 8
2023 299 407 19 963 168 439 69 769 39 066 4
2022 83 568 -897 50 021 39 870 19 103 1

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
-132.5 %
Net profit / revenue
Return on equity (ROE)
-18.9 %
Net profit / equity
Return on assets (ROA)
-18.8 %
Net profit / assets
Equity ratio
99.7 %
Equity / assets
Debt ratio
0.3 %
Liabilities / assets
Current ratio
357.51
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 16 Mar 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 28 Mar 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 27 Mar 2024 Company’s own e-Äriregister
2022 28 Jul 2022 – 31 Dec 2022 30 May 2023 Company’s own e-Äriregister

Board

Owners

Beneficial owners

  • Aime Meltsas
    Member of a senior management body (management or supervisory board) · since 28 Jul 2022

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 86211General medical practice activities Main

History of changes

What Value Period
Status In liquidation 2 Sep 2026 – now
Status Active 28 Jul 2022 – now

Rulings 4

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50207477 / 3
2 Sep 2026
 Termination entry In force
2 Sep 2026
 PDF
Ä 50207477 / 2
1 Sep 2023
 Amendment entry In force
1 Sep 2023
 PDF
Ä 50207477
28 Jul 2022
 First entry In force
28 Jul 2022
 PDF
Ä 50207477 / M1
27 Jul 2022
 Ruling to eliminate deficiencies 26 Aug 2022 Deficiencies eliminated
28 Jul 2022
 PDF

Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data